collection
https://read.qxmd.com/read/32928750/hepatorenal-syndrome-pathophysiology-diagnosis-and-management
#1
REVIEW
Douglas A Simonetto, Pere Gines, Patrick S Kamath
Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate. Hepatorenal syndrome is diagnosed when kidney function is reduced but evidence of intrinsic kidney disease, such as hematuria, proteinuria, or abnormal kidney ultrasonography, is absent. Unlike other causes of acute kidney injury (AKI), hepatorenal syndrome results from functional changes in the renal circulation and is potentially reversible with liver transplantation or vasoconstrictor drugs...
September 14, 2020: BMJ: British Medical Journal
https://read.qxmd.com/read/31534817/exercise-as-a-prescription-for-patients-with-various-diseases
#2
REVIEW
Xin Luan, Xiangyang Tian, Haixin Zhang, Rui Huang, Na Li, Peijie Chen, Ru Wang
A growing understanding of the benefits of exercise over the past few decades has prompted researchers to take an interest in the possibilities of exercise therapy. Because each sport has its own set of characteristics and physiological complications that tend to occur during exercise training, the effects and underlying mechanisms of exercise remain unclear. Thus, the first step in probing the effects of exercise on different diseases is the selection of an optimal exercise protocol. This review summarizes the latest exercise prescription treatments for 26 different diseases: musculoskeletal system diseases (low back pain, tendon injury, osteoporosis, osteoarthritis, and hip fracture), metabolic system diseases (obesity, type 2 diabetes, type 1 diabetes, and nonalcoholic fatty liver disease), cardio-cerebral vascular system diseases (coronary artery disease, stroke, and chronic heart failure), nervous system diseases (Parkinson's disease, Huntington's disease, Alzheimer's disease, depression, and anxiety disorders), respiratory system diseases (chronic obstructive pulmonary disease, interstitial lung disease, and after lung transplantation), urinary system diseases (chronic kidney disease and after kidney transplantation), and cancers (breast cancer, colon cancer, prostate cancer, and lung cancer)...
September 2019: Journal of Sport and Health Science
https://read.qxmd.com/read/31589745/the-2018-esc-esh-hypertension-guideline-and-the-2019-nice-hypertension-guideline-how-and-why-they-differ
#3
JOURNAL ARTICLE
Terry McCormack, Rebecca J Boffa, Nicholas R Jones, Serena Carville, Richard J McManus
No abstract text is available yet for this article.
November 1, 2019: European Heart Journal
https://read.qxmd.com/read/26621945/faints-fits-and-funny-turns-for-the-physician
#4
JOURNAL ARTICLE
Rohani Omar
The diagnosis and management of the dizzy patient presents the physician with significant challenges. Dizziness and imbalance are common complaints among the general population, affecting around one-third of people over the age of 65 years, and can result from a range of causes spanning many medical disciplines. The ability to take a thorough, accurate history with a logical framework for formulating a differential diagnosis is essential given the many ways that symptoms of dizziness can present. An understanding of the key features of the vestibular examination, and consideration of other pathologies including neurological and cardiac, are important...
December 2015: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/31060074/hypertension
#5
JOURNAL ARTICLE
James Brian Byrd, Robert D Brook
Recent guidelines on diagnosis and management of high blood pressure (BP) include substantial changes and several new concepts compared with previous guidelines. These are reviewed and their clinical implications are discussed in this article. The goal is to provide a practical reference to assist clinicians with up-to-date management of patients with high BP. Important issues include new diagnostic thresholds, out-of-office BP monitoring, intensified treatment goals, and a different approach to resistant hypertension...
May 7, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/30715135/management-of-blood-cholesterol
#6
COMMENT
Francis J Alenghat, Andrew M Davis
No abstract text is available yet for this article.
February 26, 2019: JAMA
https://read.qxmd.com/read/30826740/atrial-fibrillation-and-stroke-a-practical-guide
#7
REVIEW
Jonathan Gordon Best, Robert Bell, Mohammed Haque, Arvind Chandratheva, David John Werring
Neurologists and stroke physicians will be familiar with atrial fibrillation as a major cause of ischaemic stroke, and the role of anticoagulation in preventing cardioembolic stroke. However, making decisions about anticoagulation for individual patients remains a difficult area of clinical practice, balancing the serious risk of ischaemic stroke against that of major bleeding, particularly intracranial haemorrhage. Atrial fibrillation management requires interdisciplinary collaboration with colleagues in cardiology and haematology...
June 2019: Practical Neurology
https://read.qxmd.com/read/30852913/cardiorenal-syndrome-classification-pathophysiology-diagnosis-and-treatment-strategies-a-scientific-statement-from-the-american-heart-association
#8
JOURNAL ARTICLE
Janani Rangaswami, Vivek Bhalla, John E A Blair, Tara I Chang, Salvatore Costa, Krista L Lentine, Edgar V Lerma, Kenechukwu Mezue, Mark Molitch, Wilfried Mullens, Claudio Ronco, W H Wilson Tang, Peter A McCullough
Cardiorenal syndrome encompasses a spectrum of disorders involving both the heart and kidneys in which acute or chronic dysfunction in 1 organ may induce acute or chronic dysfunction in the other organ. It represents the confluence of heart-kidney interactions across several interfaces. These include the hemodynamic cross-talk between the failing heart and the response of the kidneys and vice versa, as well as alterations in neurohormonal markers and inflammatory molecular signatures characteristic of its clinical phenotypes...
April 16, 2019: Circulation
https://read.qxmd.com/read/28192793/nonpharmacologic-therapies-for-low-back-pain-a-systematic-review-for-an-american-college-of-physicians-clinical-practice-guideline
#9
REVIEW
Roger Chou, Richard Deyo, Janna Friedly, Andrea Skelly, Robin Hashimoto, Melissa Weimer, Rochelle Fu, Tracy Dana, Paul Kraegel, Jessica Griffin, Sara Grusing, Erika D Brodt
BACKGROUND: A 2007 American College of Physicians guideline addressed nonpharmacologic treatment options for low back pain. New evidence is now available. PURPOSE: To systematically review the current evidence on nonpharmacologic therapies for acute or chronic nonradicular or radicular low back pain. DATA SOURCES: Ovid MEDLINE (January 2008 through February 2016), Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and reference lists...
April 4, 2017: Annals of Internal Medicine
https://read.qxmd.com/read/29859806/dizziness
#10
REVIEW
Gregory T Whitman
Dizziness is a common symptom encountered by all physicians. Dizziness and related symptoms are frequently linked to 1 or more of a list of contributors that includes benign paroxysmal positional vertigo, Ménière disease, migraine, acute peripheral vestibulopathy, cerebral ischemia, and anxiety disorders. Awareness of these common clinical patterns increases the likelihood of making a rapid, accurate diagnosis.
December 2018: American Journal of Medicine
https://read.qxmd.com/read/29667175/first-line-drugs-for-hypertension
#11
REVIEW
James M Wright, Vijaya M Musini, Rupam Gill
BACKGROUND: This is the first update of a review published in 2009. Sustained moderate to severe elevations in resting blood pressure leads to a critically important clinical question: What class of drug to use first-line? This review attempted to answer that question. OBJECTIVES: To quantify the mortality and morbidity effects from different first-line antihypertensive drug classes: thiazides (low-dose and high-dose), beta-blockers, calcium channel blockers, ACE inhibitors, angiotensin II receptor blockers (ARB), and alpha-blockers, compared to placebo or no treatment...
April 18, 2018: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/24625386/severe-acute-pyelonephritis-a-review-of-clinical-outcome-and-risk-factors-for-mortality
#12
JOURNAL ARTICLE
Vera Y Chung, C K Tai, C W Fan, C N Tang
OBJECTIVE. To review demographics of patients with acute pyelonephritis, their outcomes of severe upper urinary tract infection, and to identify risk factors for long hospital stay and mortality. DESIGN. Case series. SETTING. A regional hospital in Hong Kong. PATIENTS. Patients admitted between June 2007 and June 2012 for acute pyelonephritis were identified. Those with the most severe outcomes were analysed of their mortality, need for care in the intensive care unit, or necessitation of urological intervention...
August 2014: Hong Kong Medical Journal
https://read.qxmd.com/read/22030767/meeting-the-challenge-of-practice-quality-improvement-a-study-of-seven-family-medicine-residency-training-practices
#13
RANDOMIZED CONTROLLED TRIAL
Sabrina M Chase, William L Miller, Eric Shaw, Anna Looney, Benjamin F Crabtree
PURPOSE: Incorporating quality improvement (QI) into resident education and clinical care is challenging. This report explores key characteristics shaping the relative success or failure of QI efforts in seven primary care practices serving as family medicine residency training sites. METHOD: The authors used data from the 2002-2008 Using Learning Teams for Reflective Adaptation study to conduct a comparative case analysis. This secondary data analysis focused on seven residency training practices' experiences with the reflective adaptive process (RAP), a 12-week intensive QI process...
December 2011: Academic Medicine
https://read.qxmd.com/read/28558102/the-troponin-cascade-a-teachable-moment
#14
JOURNAL ARTICLE
Timothy J Judson, Leila Y Beach, Krishan Soni
No abstract text is available yet for this article.
August 1, 2017: JAMA Internal Medicine
https://read.qxmd.com/read/29159375/the-2017-clinical-practice-guideline-for-high-blood-pressure
#15
JOURNAL ARTICLE
Paul K Whelton, Robert M Carey
No abstract text is available yet for this article.
December 5, 2017: JAMA
https://read.qxmd.com/read/25954497/management-of-cirrhotic-ascites
#16
REVIEW
Julie Steen Pedersen, Flemming Bendtsen, Søren Møller
The most common complication to chronic liver failure is ascites. The formation of ascites in the cirrhotic patient is caused by a complex chain of pathophysiological events involving portal hypertension and progressive vascular dysfunction. Since ascites formation represents a hallmark in the natural history of chronic liver failure it predicts a poor outcome with a 50% mortality rate within 3 years. Patients with ascites are at high risk of developing complications such as spontaneous bacterial peritonitis, hyponatremia and progressive renal impairment...
May 2015: Therapeutic Advances in Chronic Disease
https://read.qxmd.com/read/14997779/upper-airway-obstruction
#17
REVIEW
P B Baines, R E Sarginson
No abstract text is available yet for this article.
February 2004: Hospital Medicine
https://read.qxmd.com/read/26045334/-practical-judgment-and-burn-out-syndrome-among-physicians
#18
JOURNAL ARTICLE
J-C Weber
The growing incidence of burn-out syndrome among physicians has become a major concern for public policy. The root causes are not fully understood. We make the assumption that the most powerful cause of their suffering at work is the challenging of physician's practical judgment. Practical judgment is the faculty, which connects knowledge and reason, science and experience, general and individual issues. It lies at the core of medical action and its exercise is closely associated with a pleasure at work. The evolution of medicine, particularly the proliferation of procedures, has a harmful influence on its training and its exercise...
August 2015: La Revue de Médecine Interne
https://read.qxmd.com/read/23139286/cardiorenal-syndrome-the-emerging-role-of-protein-bound-uremic-toxins
#19
REVIEW
Suree Lekawanvijit, Andrew R Kompa, Bing H Wang, Darren J Kelly, Henry Krum
Cardiorenal syndrome is a condition in which a complex interrelationship between cardiac dysfunction and renal dysfunction exists. Despite advances in treatment of both cardiovascular and kidney disease, cardiorenal syndrome remains a major global health problem. Characteristic of the pathophysiology of cardiorenal syndrome is bidirectional cross-talk; mediators/substances activated by the disease state of 1 organ can play a role in worsening dysfunction of the other by exerting their biologically harmful effects, leading to the progression of the syndrome...
November 9, 2012: Circulation Research
https://read.qxmd.com/read/28735855/dementia-prevention-intervention-and-care
#20
REVIEW
Gill Livingston, Andrew Sommerlad, Vasiliki Orgeta, Sergi G Costafreda, Jonathan Huntley, David Ames, Clive Ballard, Sube Banerjee, Alistair Burns, Jiska Cohen-Mansfield, Claudia Cooper, Nick Fox, Laura N Gitlin, Robert Howard, Helen C Kales, Eric B Larson, Karen Ritchie, Kenneth Rockwood, Elizabeth L Sampson, Quincy Samus, Lon S Schneider, Geir Selbæk, Linda Teri, Naaheed Mukadam
No abstract text is available yet for this article.
December 16, 2017: Lancet
label_collection
label_collection
8878
1
2
2017-10-16 00:19:05
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.